2017
A. Polcher, Frommann, I., Koppara, A., Wolfsgruber, S., Jessen, F., and Wagner, M.,
“Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1185-1196, 2017.
M. Carmona-Iragui, Santos, T., Videla, S., Fernández, S., Benejam, B., Videla, L., Alcolea, D., Blennow, K., Blesa, R., Lleo, A., and Fortea, J.,
“Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1489-1496, 2017.
M. Carmona-Iragui, Santos, T., Videla, S., Fernández, S., Benejam, B., Videla, L., Alcolea, D., Blennow, K., Blesa, R., Lleo, A., and Fortea, J.,
“Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1489-1496, 2017.
G. Viticchi, Falsetti, L., Buratti, L., Sajeva, G., Luzzi, S., Bartolini, M., Provinciali, L., and Silvestrini, M.,
“Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia.”,
J Alzheimers Dis, vol. 59, no. 1, pp. 67-75, 2017.
K. N. H. Dillen, Jacobs, H. I. L., Kukolja, J., Richter, N., von Reutern, B., Onur, Ö. A., Langen, K. - J., and Fink, G. R.,
“Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.”,
J Alzheimers Dis, vol. 59, no. 1, pp. 169-187, 2017.
P. D. Mehta, Blain, J. - F., Freeman, E. A., Patrick, B. A., Barshatzky, M., Hrdlicka, L. A., Mehta, S. P., Frackowiak, J., Mazur-Kolecka, B., Wegiel, J., Patzke, H., and Miller, D. L.,
“Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1-37 (Aβ37).”,
J Alzheimers Dis, vol. 57, no. 1, pp. 135-145, 2017.
P. D. Mehta, Blain, J. - F., Freeman, E. A., Patrick, B. A., Barshatzky, M., Hrdlicka, L. A., Mehta, S. P., Frackowiak, J., Mazur-Kolecka, B., Wegiel, J., Patzke, H., and Miller, D. L.,
“Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1-37 (Aβ37).”,
J Alzheimers Dis, vol. 57, no. 1, pp. 135-145, 2017.
J. C. Fong, Rojas, J. C., Bang, J., Legati, A., Rankin, K. P., Forner, S., Miller, Z. A., Karydas, A. M., Coppola, G., Grouse, C. K., Ralph, J., Miller, B. L., and Geschwind, M. D.,
“Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 249-258, 2017.
J. C. Fong, Rojas, J. C., Bang, J., Legati, A., Rankin, K. P., Forner, S., Miller, Z. A., Karydas, A. M., Coppola, G., Grouse, C. K., Ralph, J., Miller, B. L., and Geschwind, M. D.,
“Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 249-258, 2017.
N. Voyle, Patel, H., Folarin, A., Newhouse, S., Johnston, C., Visser, P. Jelle, Dobson, R. J. B., and Kiddle, S. J.,
“Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1417-1427, 2017.
P. Paolo Sainaghi, Bellan, M., Lombino, F., Alciato, F., Carecchio, M., Galimberti, D., Fenoglio, C., Scarpini, E., Cantello, R., Pirisi, M., and Comi, C.,
“Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 59-65, 2017.
M. Romeo, Stravalaci, M., Beeg, M., Rossi, A., Fiordaliso, F., Corbelli, A., Salmona, M., Gobbi, M., Cagnotto, A., and Diomede, L.,
“Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.”,
J Alzheimers Dis, vol. 57, no. 3, pp. 857-871, 2017.
P. J. Fried, Schilberg, L., Brem, A. - K., Saxena, S., Wong, B., Cypess, A. M., Horton, E. S., and Pascual-Leone, A.,
“Humans with Type-2 Diabetes Show Abnormal Long-Term Potentiation-Like Cortical Plasticity Associated with Verbal Learning Deficits.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 89-100, 2017.
M. De Belder, Santens, P., Sieben, A., and Fias, W.,
“Impaired Processing of Serial Order Determines Working Memory Impairments in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 59, no. 4, pp. 1171-1186, 2017.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M.,
“Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M.,
“Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M.,
“Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M.,
“Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
J. Dronse, Fliessbach, K., Bischof, G. N., von Reutern, B., Faber, J., Hammes, J., Kuhnert, G., Neumaier, B., Onur, O. A., Kukolja, J., van Eimeren, T., Jessen, F., Fink, G. R., Klockgether, T., and Drzezga, A.,
“In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 465-471, 2017.
J. Dronse, Fliessbach, K., Bischof, G. N., von Reutern, B., Faber, J., Hammes, J., Kuhnert, G., Neumaier, B., Onur, O. A., Kukolja, J., van Eimeren, T., Jessen, F., Fink, G. R., Klockgether, T., and Drzezga, A.,
“In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 465-471, 2017.
J. Dronse, Fliessbach, K., Bischof, G. N., von Reutern, B., Faber, J., Hammes, J., Kuhnert, G., Neumaier, B., Onur, O. A., Kukolja, J., van Eimeren, T., Jessen, F., Fink, G. R., Klockgether, T., and Drzezga, A.,
“In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 465-471, 2017.
S. L. Gardener, Rainey-Smith, S. R., Sohrabi, H. R., Weinborn, M., Verdile, G., Fernando, W. M. A. D. Bino, Lim, Y. Ying, Harrington, K., Burnham, S., Taddei, K., Masters, C. L., Macaulay, S. L., Rowe, C. C., Ames, D., Maruff, P., and Martins, R. N.,
“Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner.”,
J Alzheimers Dis, vol. 58, no. 1, pp. 193-201, 2017.
F. Zimetti, Caffarra, P., Ronda, N., Favari, E., Adorni, M. Pia, Zanotti, I., Bernini, F., Barocco, F., Spallazzi, M., Galimberti, D., Ricci, C., Ruscica, M., Corsini, A., and Ferri, N.,
“Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 315-320, 2017.
F. Zimetti, Caffarra, P., Ronda, N., Favari, E., Adorni, M. Pia, Zanotti, I., Bernini, F., Barocco, F., Spallazzi, M., Galimberti, D., Ricci, C., Ruscica, M., Corsini, A., and Ferri, N.,
“Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 315-320, 2017.
] 